Rs 82 to Rs 235: This hotel company delivered 186% returns in two years!

Rs 82 to Rs 235: This hotel company delivered 186% returns in two years!

by 5paisa Research Team Last Updated: Jun 01, 2022 - 01:51 pm 26.2k Views

The Indian Hotels Co Ltd has turned into a multibagger stock after delivering exceptional returns to its shareholders in the last two years.

Hospitality industry had a massive setback during the pandemic. The Indian Hotels Company Ltd has not only managed to rebuild its business but also delivered returns to its shareholders. Its stock price has risen by over 186% in the last two years, going from Rs 81.59 on 1 June 2020 to Rs 235 on 31 May 2022.

The Indian Hotels Company Limited, which is a part of the S&P BSE 200, is South Asia’s largest hospitality company by market capitalization. It is managed as a subsidiary of Tata Group. With businesses ranging from iconic luxury to upscale and budget stopovers as well as in-flight catering, IHCL’s pioneering leadership is backed by a rich 115-year legacy.

IHCL’s emerging initiatives in urban leisure, service retail, and concept travel are a part of its evolution, one that is continuously recrafted for future generations. IHCL, through all its vivid brands - Taj, SeleQtions, Vivanta, The Gateway, Ginger, Expressions, and TajSATS - believes in adding passion to the process.

On a consolidated basis, the company has reported a net profit of Rs 71.57 crore for the current quarter as compared to a net loss of Rs 97.72 crore for the same quarter last year. The total income of the company increased by 52.42% to Rs 954.88 crore for Q4FY22 as compared to Rs 626.47 crore in the last quarter.

At 1:35 pm, the shares of Indian Hotel Co. Ltd were trading at Rs 235.45, an increase of 0.17%. The stock has a 52-week high and low of Rs 268.85 and Rs 117.59, respectively on BSE.

Share Market Today


How do you rate this article?

or

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

378X91-D3

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Open Free Demat Account
Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
BSE to Discontinue Stop Loss Market Orders for All Segments from October 9

Bombay Stock Exchange (BSE) has announced the discontinuation of Stop Loss Market (SL-M) orders, effective from October 9. This decision follows a recent incident involving a "freak trade" triggered by an SL-M order, which led to concerns within the trading community. The aim is to prevent erroneous order placements, whether they result from manual or algorithmic trading.

  • Oct 03, 2023
Valiant Laboratories IPO: Closing subscription details

Valiant Laboratories Ltd has a face value of ₹10 per share while the price band for the book building IPO has been set in the band of ₹133 to ₹140 per share. The final price will be discovered within this band, through the process of book building. The fresh issue portion entailed the issue of 1,08,90,000 shares (108.90 lakh shares), which at the upper price band of ₹140 per share will translate into fresh issue size of ₹152.46 crore.

  • Oct 03, 2023
Saakshi Medtech IPO: Listing day Update

Premium listing for Saakshi Medtech and Panels Ltd, then hits upper circuit Saakshi Medtech and Panels Ltd had a strong listing on 03rd October 2023, listing at a premium of 50.52%, and subsequently hitting the 5% upper circuit on

  • Oct 03, 2023